問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Taichung Veterans General Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2015-07-01 - 2020-12-31
Condition/Disease
stage IIIB/IV or recurrent non-small cell lung cancer
Test Drug
Opdivo®
Participate Sites10Sites
Not yet recruiting1Sites
Terminated8Sites
Division of Thoracic Medicine
2008-05-01 - 2010-12-31
Participate Sites4Sites
Terminated4Sites
2007-11-15 - 2008-06-30
Participate Sites24Sites
Terminated23Sites
Study ended1Sites
2010-01-01 - 2010-07-31
Participate Sites5Sites
Terminated5Sites
2007-09-01 - 2008-08-31
Study ended4Sites
2010-06-01 - 2011-12-31
Participate Sites14Sites
Terminated1Sites
Study ended13Sites
2015-09-01 - 2018-11-30
Acute Inner Ear Hearing Loss
AM-111
Participate Sites9Sites
Terminated9Sites
2015-12-01 - 2016-12-30
Acute Hematogenous Osteomyelitis
daptomycin (CUBICIN)
2023-09-30 - 2026-12-31
Participate Sites2Sites
Recruiting2Sites
2022-06-13 - 2024-05-24
Participate Sites3Sites
Recruiting3Sites
全部